Abstract

Stereotactic radiosurgery (SRS) is booming as the number of installed systems and procedures increases and as the indications for these procedures in the brain and elsewhere in the body increase. In most cases SRS is not the sole option for treating a lesion, and so selecting the most appropriate treatment modality can be a bewildering and contentious exercise, despite the collaboration between radiation oncologists and neurosurgeons fostered by radiosurgery. The historical practice of classifying SRS by the system used to deliver it (e.g., “GammaKnife” or “CyberKnife radiosurgery”) has exacerbated this problem.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call